The Mission of the FY23 PCRP is to fund research that will lead to the eliminate death and suffering from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care; therefore, applications are required to address one or more of the following FY23 PCRP Overarching Challenges:
• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop new treatments or improve upon existing therapies to improve outcomes for men with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of prostate cancer progression to lethal prostate cancer to reduce death
The PI must be a physician with clinical duties and/or responsibilities who, by the application submission deadline, is either: • In the last year of an accredited graduate medical education program, either as a resident or fellow, or • Within 5 years of having initiated their first faculty appointment (including instructor positions).
Each investigator may be named on only one FY23 PCRP Physician Research Award application as a PI.
The anticipated direct costs budgeted for the entire period of performance for an FY23 PCRP Physician Research Award should not exceed $750,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.